| Literature DB >> 31349828 |
Hossein Mahmoudvand1, Mahbobeh Pakravanan2, Mohammad Reza Aflatoonian3, Amal Khudair Khalaf4, Massumeh Niazi5, Seyyed Reza Mirbadie6, Amir Tavakoli Kareshk7, Mehrdad Khatami8.
Abstract
BACKGROUND: One of the most important ways to cure hydatid cysts is surgery. Today, available chemical drugs have shown severe complications during hydatid cyst surgery. Here we investigated theefficacy and safety of Curcuma longa (C. longa) essential oil (CLEO) against hydatid cysts protoscoleces.Entities:
Keywords: Cystic echinococcosis; Echinococcus granulosus; GC/MS; Protoscoleces; Turmeric
Year: 2019 PMID: 31349828 PMCID: PMC6660933 DOI: 10.1186/s12906-019-2527-3
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
GC/MS analysis of C. longa essential oil
| No | Components | KIa | % Composition |
|---|---|---|---|
| 1 | α- Thujene | 7.434 | 0.7 |
| 2 | α- Pinene | 7.66 | 0.5 |
| 3 | β- Myrcene | 9.48 | 0.8 |
| 4 | l-Phellandrene | 9.97 | 8.8 |
| 5 | ρ -Cymene | 10.47 | 5.4 |
| 6 | 1,8-Cineole | 10.72 | 3.7 |
| 7 | Limonene | 10.76 | 0.5 |
| 8 | α- Terpineolene | 12.68 | 0.8 |
| 9 | trans-Caryophyllene | 22.43 | 1.8 |
| 10 | α-Caryophyllene | 23.25 | 0.5 |
| 11 | α-Curcumene | 23.84 | 4.4 |
| 12 | α-Zingibirene | 24.25 | 3.2 |
| 13 | β-Bisabolene | 24.58 | 0.9 |
| 14 | β-Sesquiphellandrene | 24.94 | 4.2 |
| 15 | 2-Phenyl-1-D1-Aziridine | 25.87 | 1.47 |
| 16 | β- Caryophyllene | 26.12 | 0.9 |
| 17 | β-Atlantone | 26.25 | 0.9 |
| 18 | 1,3,5-Cycloheptatriene | 26.35 | 1.4 |
| 19 | Pyrazine | 26.45 | 0.7 |
| 20 | β- Bisabolene | 26.87 | 0.8 |
| 21 | γ-Curcumene | 27.23 | 2.1 |
| 22 | β- Tumerone | 27.90 | 21.8 |
| 23 | Ar-Tumerone | 28.10 | 14.7 |
| 24 | α-Tumerone | 28.74 | 12.4 |
| 25 | 3-Fluorophenyl isocyanate | 29.91 | 0.5 |
| α-Atlantone | 30.20 | 1.6 | |
| Total | 95.5 |
aKovats index on non-polar DB-5 ms column in reference to n-alkanes
In vitro protoscolicidal effects of C. longa essential oil against protoscoleces of hydatid cyst at various concentrations following various exposure times
| Concentration (μL/mL( | Exposure time (min) | Mean of mortality rate (%) |
|---|---|---|
| 200 | 5 | 100 ± 0.0 |
| 10 | – | |
| 20 | – | |
| 30 | – | |
| 100 | 5 | 76.6 ± 3.6 |
| 10 | 100 ± 0.0 | |
| 20 | – | |
| 30 | – | |
| 50 | 5 | 27.0 ± 3.15 |
| 10 | 53.3 ± 2.88 | |
| 20 | 100 ± 0.0 | |
| 30 | – | |
| Normal saline + tween 20 | 5 | 0.66 ± 0.57 |
| 10 | 2.6 ± 1.15 | |
| 20 | 3.0 ± 0.5 | |
| 30 | 4.3 ± 1.15 | |
| Ag-nitrate | 5 | 71.6 ± 2.88 |
| 10 | 100 ± 0.0 | |
| 20 | – | |
| 30 | – |
Fig. 1Live (a) and death (b) protoscoleces of hydatid cysts after exposure with 0.1% eosin
Fig. 2Ex vivo protoscolicidal effects of C. longa essential oil against protoscoleces of hydatid cyst at various concentrations following various exposure times
Clinical chemistry parameters in mice sera following oral administration of C. longa essential oil for 2 weeks
| Parameters | Control | |||
|---|---|---|---|---|
| 0.15 | 0.3 | 0.6 | ||
| AST (U/L) | 142.3 ± 11.5 | 131 ± 9.3 | 137 ± 12.5 | 141 ± 13.5 |
| ALT (U/L) | 88.6 ± 3.3 | 97.3 ± 4.6 | 104.5 ± 7.6 | 93.4 ± 8.3 |
| ALP (U/L) | 248.3 ± 23.3 | 239.6 ± 19.5 | 251.5 ± 20.4 | 235.6 ± 11.5 |
| Cr (mg/dL) | 0.4 ± 0.05 | 0.37 ± 0.08 | 0.46 ± 0.1 | 0.35 ± 0.05 |
| BUN (mg/dL) | 43.3 ± 7.2 | 29.6 ± 8.3 | 39.3 ± 7.1 | 34 ± 3.4 |
| TB (mg/dL) | 0.79 ± 0.11 | 0.69 ± 0.15 | 0.81 ± 0.2 | 0.76 ± 0.2 |
| DB (mg/dL) | 0.38 ± 0.06 | 0.28 ± 0.03 | 0.39 ± 0.05 | 0.33 ± 0.01 |
AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, Cr creatinine, BUN Blood urea nitrogen, TB Total bilirubin, DB Direct bilirubin
Hematology parameters in whole blood of mice following oral administration of C. longa essential oil for 2 weeks
| Parameters | Control | |||
|---|---|---|---|---|
| 0.15 | 0.3 | 0.6 | ||
| RBC (×l06/μL) | 3.8 ± 0.15 | 3.2 ± 0.25 | 4.2 ± 0.41 | 3.4 ± 0.3 |
| HGB (g/dL) | 11.6 ± 0.7 | 10.7 ± 1.17 | 12.3 ± 0.6 | 11.3 ± 0.45 |
| Hct (%) | 31.6 ± 3.1 | 35.1 ± 2.51 | 35.2 ± 2.6 | 32.6 ± 2.18 |
| WBC (×l03/μL) | 3.3 ± 0.35 | 2.6 ± 0.16 | 3.4 ± 0.25 | 2.9 ± 0.2 |
| PLT (×l03/μL) | 177 ± 15 | 212 ± 18 | 197 ± 12 | 185 ± 17 |
RBC red blood cell, HGB hemoglobin, Hct hematocrit, WBC white blood cell, PLT platelet